$MRNS News Article - Marinus Launches Expanded Access Program for Ganaxolone Treatment in CDKL5 Deficiency Disorder https://marketwirenews.com/news-releases/mari...69632.html
Marinus Pharmaceuticals Inc. (MRNS) Stock Research Links
My Twitter: WhyteStocks